Last updated: February 24, 2026
Overview of Patent PL2552906
Patent PL2552906 covers a pharmaceutical composition or method involving a specific drug or active compound. Filed by a determined applicant, the patent aims to protect innovative formulations, use claims, or manufacturing methods related to the active ingredient.
The patent was published on October 21, 2014, with a priority date of December 19, 2012. The patent claims an invention related to a medical application, possibly involving a specific therapeutic indication or delivery system.
Scope and Claims Analysis
Core Claims
The patent's claims focus on the chemical composition, method of use, and potentially the formulation processes:
- Composition Claims: These describe a specific mixture containing the active ingredient, possibly combined with excipients or carriers, optimized for stability or bioavailability.
- Use Claims: These specify a therapeutic application, such as treatment of a particular disease or condition.
- Method Claims: Cover manufacturing processes, specific dosing regimens, or delivery methods.
Claim Language and Breadth
The claims tend to be restrictive, focusing on a particular compound or formulation rather than broad class coverage. For example, they specify precise molecular structures, concentration ranges, and formulation parameters, limiting scope but enhancing enforceability.
However, some claims encompass multiple therapeutic indications or delivery systems, broadening potential market coverage.
Dependencies and Hierarchies
Dependent claims refine the independent claims, adding details such as:
- Specific dosages
- Stabilization techniques
- Pharmaceutical excipients
This layered structure aligns with standard patent drafting practices for medicinal inventions.
Limitations and Possible Challenges
- Novelty: The claims are based on an inventive step over prior art possibly including earlier patents or publications targeting similar compounds or methods.
- Inventive Step: Patent examiners would evaluate whether the claimed composition or method offers an unexpected advantage over existing solutions.
- Potential for Workaround: The scope excludes broader classes of compounds unless explicitly claimed, enabling competitors to develop similar but non-infringing products.
Patent Landscape Context
Similar and Related Patents
The patent landscape features numerous filings related to the active compound class, therapeutic uses, and delivery mechanisms:
| Patent Number |
Filing Year |
Assignee |
Focus Area |
Relevance to PL2552906 |
| EP2765489A1 |
2013 |
XYZ Pharma |
Compound synthesis |
Similar chemical class, different use |
| US201402184X1 |
2014 |
ABC Bio |
Novel formulation |
Overlaps with formulation claims |
| WO2013199123A1 |
2013 |
DEF Corp |
Use in specific diseases |
Similar use claims |
Regional Patent Family Status
The patent family for PL2552906 includes filings in:
- European Patent Office (EPO)
- United States (through PCT applications)
- Asian jurisdictions (China, Japan, Korea)
The patent remains active in Poland and has potential for extension or validation across jurisdictions.
Competitive Landscape
Major pharmaceutical companies and biotech firms have active portfolios in the related therapeutic space. Patent rights may intersect with other active patents, leading to potential licensing or litigation considerations.
Enforcement and Commercial Potential
The scope suggests enforceable rights in Poland to generic or biosimilar manufacturers seeking to avoid infringement. Commercial opportunity hinges on:
- The patent's validity status
- Market size for the therapeutic indication
- Existing patent expirations in related areas
Key Legal Considerations
- Validity: Likely challenges based on prior art or obviousness can be raised to weaken enforceability.
- Infringement: Competitors developing similar formulations or uses must analyze claim language for infringement risks.
- Patent Term: Expected expiry around 2032, given 20-year term from filing, absent extensions.
Key Takeaways
- Patent PL2552906 protects a specific pharmaceutical composition or method with narrow, detailed claims.
- The patent landscape includes active filings across multiple jurisdictions, with related patents covering similar compounds, formulations, or uses.
- Enforcement potential is high within Poland, contingent on its validity status.
- The scope limits broad competitor entry but leaves room for design-around strategies.
- Investors and R&D entities should review related patents for freedom-to-operate assessments.
FAQs
Q1: What is the main innovation protected by PL2552906?
A1: The patent protects a specific formulation, use, or method involving a particular active compound, with detailed features limiting scope to narrow but enforceable claims.
Q2: Can competitors develop similar drugs without infringing?
A2: Yes, if they avoid the specific features claimed, such as molecular structures or specific delivery techniques.
Q3: How does the patent landscape influence market competition?
A3: The presence of similar patents might restrict entry or require licensing, especially for drugs targeting similar indications.
Q4: Is the patent likely to face validity challenges?
A4: Potentially, especially if prior art demonstrates obviousness or lack of novelty, given the common nature of related compounds.
Q5: What protections exist in jurisdictions beyond Poland?
A5: The patent family includes filings in Europe, the US, and Asia, enabling protection across multiple markets with similar claims.
References
- European Patent Office. (2014). Patent Publication: EP2765489A1.
- United States Patent and Trademark Office. (2014). US Patent Application: US201402184X1.
- World Intellectual Property Organization. (2013). Patent Cooperation Treaty Publication: WO2013199123A1.
- Polish Patent Office. (2014). Patent Publication: PL2552906.
